Johnson Johnson to supply Georgia with coronavirus vaccines


(MENAFN- Trend News Agency ) BAKU, Azerbaijan, September 17

By Tamilla Mammadova – Trend:

The Jonson & Jonson coronavirus vaccine is planned to be delivered to Georgia at the end of October, Trend reports referring to the Georgian media.

“The Jonson & Jonson vaccine is due in October at the latest, but this is such a small amount that it is unlikely to significantly affect the vaccination process. We are talking about only 50,000 doses, which means 50,000 vaccinated,” said the head of the National Technical Group of Immunization Consultants, medical director of the Iashvili Children's Central Hospital Ivane Chkhaidze.

He recalled that for the emergence of immunity, one vaccination with Jonson & Jonson is enough, and not two, as is the case with other vaccines.

The drug, developed by the American concern Johnson & Johnson is recognized by the World Health Organization as safe and effective in protecting people from the most serious risks associated with COVID-19, including death, hospitalization, and severe illness.

Janssen is approved by the relevant EU agency and the European Commission and is approved for use in the United States. The vaccine has passed the examination of the European Medicines Agency (EMEA) and the US Food and Drug Administration.

At the moment, Sinopharm, Sinovac, Pfizer, AstraZeneca vaccines are available in Georgia.

According to the latest data, 1.61 million vaccinations were carried out in Georgia. Of these, 935,094 people were vaccinated with one dose, 675,215 were fully vaccinated with two doses.

---

Follow the author on Twitter: @Mila61979356

MENAFN17092021000187011040ID1102815325


Trend News Agency

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.